These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36607996)

  • 1. Development and validation of Tagalog versions of the Drug Abuse Screening Test-20 (DAST-20) and Stimulant Relapse Risk Scale (SRRS) for drug users in the Philippines.
    Harada T; Nomura K; Baba T; Shirasaka T; Takano A; Kanamori S
    PLoS One; 2023; 18(1):e0280047. PubMed ID: 36607996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric validation of the Chinese Version of the stimulant relapse risk scale (SRRS) in patients with methamphetamine use disorder.
    Lin JS; Ogai Y; Lin C; Chang HM; Wu YC; Huang MC; Fang SC
    Subst Abuse Treat Prev Policy; 2024 Jul; 19(1):34. PubMed ID: 38978076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of the modified Drug Abuse Screening Test Sinhala version (DAST-SL): evaluation of reliability and validity in Sri Lanka.
    Nawaratne SD; Vidanapathirana J
    BMC Public Health; 2024 Jul; 24(1):1773. PubMed ID: 38961374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic profiles and determinants of relapse risks among people with substance use disorders in the Philippines: A survey in community and residential care settings.
    Harada T; Kanamori S; Baba T; Takano A; Nomura K; Villaroman A; Rey FI; Peralta J; Shirasaka T
    Drug Alcohol Depend; 2023 Oct; 251():110924. PubMed ID: 37633130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the Turkish versions of the Drug Use Disorders Identification Test (DUDIT) and the Drug Abuse Screening Test (DAST-10) in the prison setting.
    Evren C; Ogel K; Evren B; Bozkurt M
    J Psychoactive Drugs; 2014; 46(2):140-6. PubMed ID: 25052790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and reliability of the Mandarin Chinese version of the drug abuse screening test among adolescents in Taiwan.
    Liao JY; Chi HY; Guo JL; Huang CM; Shih SF
    Subst Abuse Treat Prev Policy; 2017 Jun; 12(1):30. PubMed ID: 28587622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Drug Abuse Screening Test preserves its excellent psychometric properties in psychiatric patients evaluated in an emergency setting.
    Giguère CÉ; Potvin S;
    Addict Behav; 2017 Jan; 64():165-170. PubMed ID: 27614056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan.
    Ogai Y; Haraguchi A; Kondo A; Ishibashi Y; Umeno M; Kikumoto H; Hori T; Komiyama T; Kato R; Aso K; Asukai N; Senoo E; Ikeda K
    Drug Alcohol Depend; 2007 May; 88(2-3):174-81. PubMed ID: 17118576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening illicit substance use in college students: The Chinese version of the Drug Abuse Screening Test.
    Chen YT; Chang JC; Lee CS
    Drug Alcohol Depend; 2020 Oct; 215():108184. PubMed ID: 32763780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an Arabic Version of the Drug Abuse Screening Test-10 (DAST-10) among Saudi Drug Abusers.
    Murad HAS; AlHarthi NA; Bakarman MA; Gazzaz ZJ
    J Psychoactive Drugs; 2022; 54(5):482-489. PubMed ID: 34955091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reliability and validity of the Japanese version of the DAST-20].
    Shimane T; Imamura A; Ikeda K; Yamamoto M; Tsuji M; Nagayo Y; Ohkubo T; Ohta M; Kanda H; Okazaki S; Ohe M; Matsumoto T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2015 Dec; 50(6):310-24. PubMed ID: 26964292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Psychometric Properties of the Drug Abuse Screening Test.
    Shirinbayan P; Salavati M; Soleimani F; Saeedi A; Asghari-Jafarabadi M; Hemmati-Garakani S; Vameghi R
    Addict Health; 2020 Jan; 12(1):25-33. PubMed ID: 32582412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community-based validation study of the short-form 36 version 2 Philippines (Tagalog) in two cities in the Philippines.
    Castillo-Carandang NT; Sison OT; Grefal ML; Sy RG; Alix OC; Llanes EJ; Reganit PF; Gumatay AW; Punzalan FE; Velandria FV; Tai ES; Wee HL
    PLoS One; 2013; 8(12):e83794. PubMed ID: 24386281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the Relapse Risk Scale to alcohol-dependent individuals in Japan: comparison with stimulant abusers.
    Ogai Y; Yamashita M; Endo K; Haraguchi A; Ishibashi Y; Kurokawa T; Muratake T; Suga R; Hori T; Umeno M; Asukai N; Senoo E; Ikeda K
    Drug Alcohol Depend; 2009 Apr; 101(1-2):20-6. PubMed ID: 19084356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of a two-item Drug Abuse Screening Test (DAST-2).
    Tiet QQ; Leyva YE; Moos RH; Smith B
    Addict Behav; 2017 Nov; 74():112-117. PubMed ID: 28609724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.
    Yudko E; Lozhkina O; Fouts A
    J Subst Abuse Treat; 2007 Mar; 32(2):189-98. PubMed ID: 17306727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and psychometric properties of the methamphetamine decisional balance scale (METH-DBS) for young adults.
    Khazaee-Pool M; Jahangiry L; Pashaei T; Ramezani-Badr F; Nadrian H; Ponnet K
    Subst Abuse Treat Prev Policy; 2018 Oct; 13(1):38. PubMed ID: 30373625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial treatment for incarcerated methamphetamine users: the Philippines experience.
    Hechanova MRM; Reyes JC; Acosta AC; Tuliao AP
    Int J Prison Health; 2020 Aug; 16(4):343-358. PubMed ID: 33634665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires.
    Delgadillo J; Payne S; Gilbody S; Godfrey C; Gore S; Jessop D; Dale V
    J Affect Disord; 2011 Nov; 134(1-3):266-71. PubMed ID: 21723619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.